button bars forest bayes pooled summary circles
 
deaths (OS)

metastatic/advanced RCC (mRCC) - 2nd line (L2) metastatic/advanced RCC (mRCC) - 2nd line (L2)

versus cabozantinib
atezolizumab plus cabozantinib vs. cabozantinib 1 NaN [NaN; NaN] /10000
0/0 vs. 0/0
versus everolimus
nivolumab alone vs. everolimus 1 -768 [-1449; -86] /10000
183/410 vs. 215/411

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons